{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:17:27Z","timestamp":1774437447787,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-025-01197-8","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T03:12:33Z","timestamp":1738120353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Value of multi-parameter 123I-MIBG scintigraphy in the differential diagnosis of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Teng","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-7676","authenticated-orcid":false,"given":"Jigang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet. 2009;373:2055\u201366.","journal-title":"Lancet"},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00441-018-2851-9","volume":"373","author":"S Orimo","year":"2018","unstructured":"Orimo S, Ghebremedhin E, Gelpi E. Peripheral and central autonomic nervous system: Does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD? Cell Tissue Res. 2018;373:267\u201386.","journal-title":"Cell Tissue Res"},{"key":"1197_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"1197_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","volume":"83","author":"CH Adler","year":"2014","unstructured":"Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014;83:406\u201312.","journal-title":"Neurology"},{"key":"1197_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14802\/jmd.15015","volume":"8","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Kim SJ. (123)I-Metaiodobenzylguanidine myocardial scintigraphy in Lewy body-related disorders: a literature review. J Mov Disord. 2015;8:55\u201366.","journal-title":"J Mov Disord"},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005;109:583\u20138.","journal-title":"Acta Neuropathol"},{"key":"1197_CR7","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","volume":"37","author":"A Flotats","year":"2010","unstructured":"Flotats A, Carri\u00f3 I, Agostini D, Le Guludec D, Marcassa C, Schaffers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM cardiovascular committee and the European council of nuclear cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1197_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg D, Borghammer P, Fereshtehnejad S-M, Heinzel S, Horsager J, Schaeffer E, et al. Prodromal Parkinson disease subtypes\u2014key to understanding heterogeneity. Nat Rev Neurol. 2021;17:349\u201361.","journal-title":"Nat Rev Neurol"},{"key":"1197_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/ene.13206","volume":"24","author":"J-S Kim","year":"2017","unstructured":"Kim J-S, Park H-E, Park I-S, Oh Y-S, Ryu D-W, Song I-U, et al. Normal \u201cheart\u201d in Parkinson\u2019s disease: Is this a distinct clinical phenotype? Eur J Neurol. 2017;24:349\u201356.","journal-title":"Eur J Neurol"},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","volume":"30","author":"S Orimo","year":"2016","unstructured":"Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in \u03b1-synucleinopathies. Ageing Res Rev. 2016;30:122\u201333.","journal-title":"Ageing Res Rev"},{"key":"1197_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.arr.2015.12.009","volume":"30","author":"DJ Brooks","year":"2016","unstructured":"Brooks DJ. Molecular imaging of dopamine transporters. Ageing Res Rev. 2016;30:114\u201321.","journal-title":"Ageing Res Rev"},{"key":"1197_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/jnnp-2015-310327","volume":"86","author":"K Tsujikawa","year":"2015","unstructured":"Tsujikawa K, Hasegawa Y, Yokoi S, Yasui K, Nanbu I, Yanagi T, et al. Chronological changes of 123 I-MIBG myocardial scintigraphy and clinical features of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2015;86:945\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1197_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1197_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","volume":"155","author":"M Yoshita","year":"1998","unstructured":"Yoshita M. Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci. 1998;155:60\u20137.","journal-title":"J Neurol Sci"},{"key":"1197_CR15","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/mds.23659","volume":"26","author":"AE King","year":"2011","unstructured":"King AE, Mintz J, Royall DR. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord. 2011;26:1218\u201324.","journal-title":"Mov Disord"},{"key":"1197_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JPD-150680","volume":"6","author":"TG Beach","year":"2016","unstructured":"Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, et al. Prevalence of submandibular gland synucleinopathy in Parkinson\u2019s disease, dementia with Lewy bodies and other Lewy body disorders. J Parkinsons Dis. 2016;6:153\u201363.","journal-title":"J Parkinsons Dis"},{"key":"1197_CR17","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1212\/WNL.0000000000000204","volume":"82","author":"CH Adler","year":"2014","unstructured":"Adler CH, Dugger BN, Hinni ML, Lott DG, Driver-Dunckley E, Hidalgo J, et al. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology. 2014;82:858\u201364.","journal-title":"Neurology"},{"key":"1197_CR18","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00259-012-2180-2","volume":"39","author":"CE Veltman","year":"2012","unstructured":"Veltman CE, Boogers MJ, Meinardi JE, Al Younis I, Dibbets-Schneider P, Van der Wall EE, et al. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012;39:1599\u2013608.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1197_CR19","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.2967\/jnumed.114.142794","volume":"56","author":"K Nakajima","year":"2015","unstructured":"Nakajima K, Nakata T. Cardiac 123 I-MIBG imaging for clinical decision making: 22-year experience in Japan. J Nucl Med. 2015;56:11S-19S.","journal-title":"J Nucl Med"},{"key":"1197_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MNM.0000000000000238","volume":"36","author":"DO Verschure","year":"2015","unstructured":"Verschure DO, De Wit TC, Bongers V, Hagen PJ, Sonneck-Koenne C, D\u2019Aron J, et al. 123I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity. Nucl Med Commun. 2015;36:279\u201385.","journal-title":"Nucl Med Commun"},{"key":"1197_CR21","doi-asserted-by":"crossref","unstructured":"Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, et al. Peripheral sympathetic dysfunction in patients with Parkinson\u2019s disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp. Eur J Nucl Med. 2000;27:566\u201373.","DOI":"10.1007\/s002590050544"},{"key":"1197_CR22","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1007\/s00415-023-11770-7","volume":"270","author":"J Ebina","year":"2023","unstructured":"Ebina J, Mizumura S, Ishii N, Kobayashi Y, Shibukawa M, Morioka H, et al. Reduced 123I-MIBG uptake in the parotid and submandibular glands in patients with Parkinson\u2019s disease identified using a quantitative semi-automatic method. J Neurol. 2023;270:4385\u201392.","journal-title":"J Neurol"},{"key":"1197_CR23","doi-asserted-by":"publisher","first-page":"1066331","DOI":"10.3389\/fnagi.2022.1066331","volume":"14","author":"S Li","year":"2023","unstructured":"Li S, Yue L, Chen S, Wu Z, Zhang J, Hong R, et al. High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson\u2019s disease. Front Aging Neurosci. 2023;14:1066331.","journal-title":"Front Aging Neurosci"},{"key":"1197_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, et al. The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37:1131\u201348.","journal-title":"Mov Disord"},{"key":"1197_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1\u20139.","journal-title":"Neurology"},{"key":"1197_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4485","volume":"366","author":"V Shanker","year":"2019","unstructured":"Shanker V. Essential tremor: diagnosis and management. BMJ. 2019;366: l4485.","journal-title":"BMJ"},{"key":"1197_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00006231-199207000-00006","volume":"13","author":"KK Solanki","year":"1992","unstructured":"Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun. 1992;13:513\u201321.","journal-title":"Nucl Med Commun"},{"key":"1197_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.parkreldis.2019.07.003","volume":"66","author":"E Schubert","year":"2019","unstructured":"Schubert E, Dogan S, Dillmann U, Schaefer-Schuler A, Fassbender K, Ezziddin S, et al. MIBG scintigraphy of the major salivary glands in progressive supranuclear palsy and corticobasal degeneration. Parkinsonism Relat Disord. 2019;66:247\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1197_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/brainsci13101471","volume":"13","author":"J Pitton Rissardo","year":"2023","unstructured":"Pitton Rissardo J, Fornari Caprara AL. Cardiac 123I-Metaiodobenzylguanidine (MIBG) scintigraphy in Parkinson\u2019s disease: a comprehensive review. Brain Sci. 2023;13:1471.","journal-title":"Brain Sci"},{"key":"1197_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0022-510X(00)00279-3","volume":"175","author":"A Druschky","year":"2000","unstructured":"Druschky A, Hilz MJ, Platsch G, Radespiel-Tr\u00f6ger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson\u2019s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci. 2000;175:3\u201312.","journal-title":"J Neurol Sci"},{"key":"1197_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10286-022-00853-6","volume":"32","author":"C Eckhardt","year":"2022","unstructured":"Eckhardt C, Krismer F, Donnemiller E, Eschlb\u00f6ck S, Fanciulli A, Raccagni C, et al. Cardiac sympathetic innervation in Parkinson\u2019s disease versus multiple system atrophy. Clin Auton Res. 2022;32:103\u201314.","journal-title":"Clin Auton Res"},{"key":"1197_CR32","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/mds.22649","volume":"24","author":"EJ Chung","year":"2009","unstructured":"Chung EJ, Lee WY, Yoon WT, Kim BJ, Lee GH. MIBG scintigraphy for differentiating Parkinson\u2019s disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Mov Disord. 2009;24:1650\u20135.","journal-title":"Mov Disord"},{"key":"1197_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/RLU.0000000000002424","volume":"44","author":"D-W Ryu","year":"2019","unstructured":"Ryu D-W, Kim J-S, Lee J-E, Oh Y-S, Yoo S-W, Yoo IR, et al. Initial versus follow-up sequential myocardial 123I-MIBG scintigraphy to discriminate Parkinson disease from atypical parkinsonian syndromes. Clin Nucl Med. 2019;44:282\u20138.","journal-title":"Clin Nucl Med"},{"key":"1197_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","volume":"113","author":"S Orimo","year":"2007","unstructured":"Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2007;113:81\u20136.","journal-title":"Acta Neuropathol"},{"key":"1197_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2018.10.019","volume":"396","author":"T Kamada","year":"2019","unstructured":"Kamada T, Miura S, Kida H, Irie K-I, Yamanishi Y, Hoshino T, et al. MIBG myocardial scintigraphy in progressive supranuclear palsy. J Neurol Sci. 2019;396:3\u20137.","journal-title":"J Neurol Sci"},{"key":"1197_CR36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.clineuro.2013.01.004","volume":"115","author":"T Adachi","year":"2013","unstructured":"Adachi T, Kitayama M, Wada-Isoe K, Nakano T, Nakashima K. Autopsy-confirmed progressive supranuclear palsy with decreased uptake of metaiodobenzylguanidine. Clin Neurol Neurosurg. 2013;115:1555\u20137.","journal-title":"Clin Neurol Neurosurg"},{"key":"1197_CR37","doi-asserted-by":"crossref","unstructured":"Jeong YJ, Jeong J-E, Cheon S-M, Yoon B-A, Kim JW, Kang D-Y. Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson\u2019s disease. Toft M, editor. PLoS ONE. 2020;15:e0229860.","DOI":"10.1371\/journal.pone.0229860"},{"key":"1197_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.parkreldis.2019.09.014","volume":"67","author":"G Lamotte","year":"2019","unstructured":"Lamotte G, Holmes C, Wu T, Goldstein DS. Long-term trends in myocardial sympathetic innervation and function in synucleinopathies. Parkinsonism Relat Disord. 2019;67:27\u201333.","journal-title":"Parkinsonism Relat Disord"},{"key":"1197_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10286-022-00859-0","volume":"32","author":"G Lamotte","year":"2022","unstructured":"Lamotte G, Goldstein DS. What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies? Clin Auton Res. 2022;32:95\u20138.","journal-title":"Clin Auton Res"},{"key":"1197_CR40","first-page":"1099","volume":"47","author":"K Kashihara","year":"2006","unstructured":"Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson\u2019s disease and dementia with Lewy bodies. J Nucl Med. 2006;47:1099\u2013101.","journal-title":"J Nucl Med"},{"key":"1197_CR41","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1007\/s00415-020-09992-0","volume":"267","author":"K Tsukita","year":"2020","unstructured":"Tsukita K, Tachibana N, Hamano T. Appropriate assessment method of 123I-MIBG myocardial scintigraphy for the diagnosis of Lewy body diseases and idiopathic REM sleep behavior disorder. J Neurol. 2020;267:3248\u201357.","journal-title":"J Neurol"},{"key":"1197_CR42","doi-asserted-by":"publisher","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","volume":"98","author":"T Matsubara","year":"2022","unstructured":"Matsubara T, Kameyama M, Tanaka N, Sengoku R, Orita M, Furuta K, et al. Autopsy validation of the diagnostic accuracy of 123I-Metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease. Neurology. 2022;98:e1648\u201359.","journal-title":"Neurology"},{"key":"1197_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s12149-022-01728-6","volume":"36","author":"S Adaniya","year":"2022","unstructured":"Adaniya S, Takahashi M, Koyama K, Ogane K, Momose T. Influence of antidepressant use on 123I-MIBG heart and lung uptakes in the diagnosis of Lewy body disease. Ann Nucl Med. 2022;36:488\u201394.","journal-title":"Ann Nucl Med"},{"key":"1197_CR44","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/biom13081263","volume":"13","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2023","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Santos-Garc\u00eda D, Mart\u00ednez-Valbuena I, Ag\u00fandez JAG. Alpha-Synuclein in peripheral tissues as a possible marker for neurological diseases and other medical conditions. Biomolecules. 2023;13:1263.","journal-title":"Biomolecules"},{"key":"1197_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.parkreldis.2016.10.011","volume":"34","author":"J Haqparwar","year":"2017","unstructured":"Haqparwar J, Pepe A, Fassbender K, Dillmann U, Ezziddin S, Schaefer A, et al. Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;34:26\u201330.","journal-title":"Parkinsonism Relat Disord"},{"key":"1197_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.26510","volume":"93","author":"K Miyamoto","year":"2023","unstructured":"Miyamoto K, Saiki S, Matsumoto H, Suzuki A, Yamashita Y, Iseki T, et al. Systemic metabolic alteration dependent on the thyroid-liver axis in early PD. Ann Neurol. 2023;93:303\u201316.","journal-title":"Ann Neurol"},{"key":"1197_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02984609","volume":"19","author":"H Matsui","year":"2005","unstructured":"Matsui H, Udaka F, Oda M, Tamura A, Kubori T, Nishinaka K, et al. Metaiodobenzylguanidine (MIBG) uptake in Parkinson\u2019s disease also decreases at thyroid. Ann Nucl Med. 2005;19:225\u20139.","journal-title":"Ann Nucl Med"},{"key":"1197_CR48","doi-asserted-by":"publisher","first-page":"1073720","DOI":"10.3389\/fmed.2022.1073720","volume":"9","author":"C Boccalini","year":"2022","unstructured":"Boccalini C, Carli G, Vanoli EG, Cocco A, Albanese A, Garibotto V, et al. Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson\u2019s disease. Front Med (Lausanne). 2022;9:1073720.","journal-title":"Front Med (Lausanne)"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01197-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01197-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01197-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T04:04:48Z","timestamp":1738123488000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-025-01197-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01197-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the local ethical review board (Beijing Friendship Hospital of Capital Medical University) and individual consent for this retrospective analysis was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}